June 27, 2017 / 11:43 AM / 2 months ago

BRIEF-Marinus Pharma initiated Phase 2 clinical trial for Ganaxolone IV

June 27 (Reuters) - Marinus Pharmaceuticals Inc:

* Marinus Pharmaceuticals- initiated its Phase 2 clinical trial to evaluate safety, efficacy and pharmacokinetics of Ganaxolone IV

* Marinus Pharmaceuticals Inc - data from initial cohort in magnolia study are expected in second half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below